News & Analysis on Clinical Trial Services & Contract Research And Development
The EMA says current GCP rules make quality management in trials too costly and need to be revised into a code that meets the needs of academics, small and midsized drugmakers and Big Pharmas alike.
in-PharmaTechnologist presents a roundup of recent ingredient and formulation research, including improved API impurity detection and a simple step to boost stability.
UPDATE
US-based contract manufacturer Ben Venue Laboratories (BVL) is to exit the CMO industry.
AstraZeneca has adopted and scaled-up silica-based cartridges for removal of metal impurities at its pilot plant.
JB Chemicals and Asymchem Laboratories are expanding in response to interest in outsourcing manufacturing to India and China.
Contract speciality chemical maker Chemspec International says it will ‘go private’ after being taken over by Halogen Limited, a holding company co-owned by members of its management board.